Richard W. Foltin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Richard W. Foltin has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Marian W. Fischman
7 shared publicationsM W Fischman
5 shared publicationsUS Department of Health and Human Services; National Institute on Drug Abuse
4 shared publicationsMargaret Haney
Division on Substance Abuse, New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, Unit 120, New York, NY 10032, USA
3 shared publications- Margaret Haney
New York State Psychiatric Institute, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, Unit 120, New York, NY 10032, USA
2 shared publications - Sandra D. Comer
Division on Substance Abuse, New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, Unit 120, New York, NY 10032, USA
2 shared publications
Latest Publications
- 14 April 2015
- Published by Springer Nature
- p. 270-274
Behavioral Tolerance
- 1 September 2012
- Published by Wolters Kluwer Health in Behavioural Pharmacology
- Vol. 23 (5 and 6) , 461-477
The behavioral pharmacology of anorexigenic drugs in nonhuman primates
Comparatively few studies over the past 30 years have used pharmacological manipulations as a means of understanding processes underlying feeding behavior of nonhuman primates. In the 1970s and early 1980s, four laboratories provided data on the anorexigenic effects of a range of drugs on rhesus monkeys and baboons, and a fifth laboratory studied the effects of neuropeptides on feeding behavior of baboons. There were differences in the way anorexigenic drugs altered eating topography, and those that increased dopamine levels had greater abuse liability than those that increased serotonin levels. Studies in the 1980s and 1990s used foraging models and principles of behavioral economics to understand food-drug interactions. Experimenter-given anorexigenic drugs did not function as economic substitutes for food. Recent studies have examined the effects of a range of drugs on consumption of highly palatable food and model diet-induced obesity. Although some drugs, including stimulants, N-methyl-D-aspartate antagonists, and a cannabinoid antagonist increased the latency to standard food consumption, there was little evidence for a selective effect of any drug on highly palatable food consumption. Results obtained in nonhuman primates did not always confirm those observed in rodents. Future studies looking at sex differences and social factors may provide insight into factors related to human obesity.
- 1 September 2012
- Published by Wolters Kluwer Health in Behavioural Pharmacology
- Vol. 23 (5 and 6) , 461-477
The behavioral pharmacology of anorexigenic drugs in nonhuman primates
Comparatively few studies over the past 30 years have used pharmacological manipulations as a means of understanding processes underlying feeding behavior of nonhuman primates. In the 1970s and early 1980s, four laboratories provided data on the anorexigenic effects of a range of drugs on rhesus monkeys and baboons, and a fifth laboratory studied the effects of neuropeptides on feeding behavior of baboons. There were differences in the way anorexigenic drugs altered eating topography, and those that increased dopamine levels had greater abuse liability than those that increased serotonin levels. Studies in the 1980s and 1990s used foraging models and principles of behavioral economics to understand food-drug interactions. Experimenter-given anorexigenic drugs did not function as economic substitutes for food. Recent studies have examined the effects of a range of drugs on consumption of highly palatable food and model diet-induced obesity. Although some drugs, including stimulants, N-methyl-D-aspartate antagonists, and a cannabinoid antagonist increased the latency to standard food consumption, there was little evidence for a selective effect of any drug on highly palatable food consumption. Results obtained in nonhuman primates did not always confirm those observed in rodents. Future studies looking at sex differences and social factors may provide insight into factors related to human obesity.
- 1 July 2011
- Published by Elsevier in Physiology & Behavior
- Vol. 103 (5) , 493-500
Consumption of palatable food decreases the anorectic effects of serotonergic, but not dopaminergic drugs in baboons
- 1 July 2011
- Published by Elsevier in Physiology & Behavior
- Vol. 103 (5) , 493-500
Consumption of palatable food decreases the anorectic effects of serotonergic, but not dopaminergic drugs in baboons
- 1 January 2010
- Published by Springer Nature
- p. 1172
Schedule of Reinforcement
- 1 January 2010
- Published by Springer Nature
- p. 214-217
Behavioral Tolerance
- 1 January 2010
- Published by Springer Nature
- p. 19
Acute Tolerance
- 15 May 2008
- Published by Springer Nature in Psychopharmacology
- Vol. 199 (4) , 583-592
A novel procedure for assessing the effects of drugs on satiation in baboons: effects of memantine and dexfenfluramine
Rationale Procedures for studying the effects of medications on satiation will assist the development of obesity medications. Objectives Develop a procedure for measuring satiation during consumption of bland and highly palatable food and determine the effect of acute intramuscular administration of dexfenfluramine (DFEN), which increases serotonin levels, and memantine (MEM), which blocks N-methyl-d-aspartate receptors. Materials and methods A modified progressive ratio (PR) procedure was used to track changes in reinforcing strength when a food was consumed. The response requirement increased after each reinforcement, and reinforcing strength was estimated using the breakpoint (BP), which was the last completed response cost. There was one preferred food (sweet candy) and one chow pellet PR session per week. During each session, four male and four female adult baboons experienced three 1-h PR trials, separated by 30 min. Chow pellets were available at all other times. We examined the BP for one to 20 candies or chow pellets. Drug effects were examined when baboons had access to one and ten candies or chow pellets. Results BPs for candy were greater than for pellets. Varying the pellet/candy pieces per delivery produced an inverted U-shaped function on the first trial, i.e., maximal BP was observed for three items, and the BP for multiple items, but not a single item, decreased across trials, i.e., BP decreased with food intake and satiation. DFEN and MEM decreased responding with the greatest effects at ten deliveries, suggesting that DFEN and MEM enhanced satiation. Conclusion Drugs that enhance satiation for several types of food may be particularly effective for decreasing food intake.
- 15 May 2008
- Published by Springer Nature in Psychopharmacology
- Vol. 199 (4) , 583-592
A novel procedure for assessing the effects of drugs on satiation in baboons: effects of memantine and dexfenfluramine
Rationale Procedures for studying the effects of medications on satiation will assist the development of obesity medications. Objectives Develop a procedure for measuring satiation during consumption of bland and highly palatable food and determine the effect of acute intramuscular administration of dexfenfluramine (DFEN), which increases serotonin levels, and memantine (MEM), which blocks N-methyl-d-aspartate receptors. Materials and methods A modified progressive ratio (PR) procedure was used to track changes in reinforcing strength when a food was consumed. The response requirement increased after each reinforcement, and reinforcing strength was estimated using the breakpoint (BP), which was the last completed response cost. There was one preferred food (sweet candy) and one chow pellet PR session per week. During each session, four male and four female adult baboons experienced three 1-h PR trials, separated by 30 min. Chow pellets were available at all other times. We examined the BP for one to 20 candies or chow pellets. Drug effects were examined when baboons had access to one and ten candies or chow pellets. Results BPs for candy were greater than for pellets. Varying the pellet/candy pieces per delivery produced an inverted U-shaped function on the first trial, i.e., maximal BP was observed for three items, and the BP for multiple items, but not a single item, decreased across trials, i.e., BP decreased with food intake and satiation. DFEN and MEM decreased responding with the greatest effects at ten deliveries, suggesting that DFEN and MEM enhanced satiation. Conclusion Drugs that enhance satiation for several types of food may be particularly effective for decreasing food intake.
- 1 April 2007
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 86 (4) , 766-773
Effects of the cannabinoid antagonist SR141716 (rimonabant) and d-amphetamine on palatable food and food pellet intake in non-human primates
- 1 April 2007
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 86 (4) , 766-773
Effects of the cannabinoid antagonist SR141716 (rimonabant) and d-amphetamine on palatable food and food pellet intake in non-human primates